Exchange Announcement • 08 Oct 2026 06:37
Voluntary Announcement - Phase I Clinical Trial Application Submission Of Rbd3133 Injection For Overweight And Obesity
Exchange Announcement • 21 Sep 2026 16:31
2026 Interim Report
Exchange Announcement • 16 Sep 2026 19:58
Next Day Disclosure Return
Exchange Announcement • 11 Sep 2026 21:30
Next Day Disclosure Return
Exchange Announcement • 09 Sep 2026 19:12